The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-5-((4-(Methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)-amino)-3-(piperidin-3-yloxy)picolinonitrile ID: ALA4860336
PubChem CID: 164618132
Max Phase: Preclinical
Molecular Formula: C17H18F3N7O
Molecular Weight: 393.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNc1nc(Nc2cnc(C#N)c(O[C@@H]3CCCNC3)c2)ncc1C(F)(F)F
Standard InChI: InChI=1S/C17H18F3N7O/c1-22-15-12(17(18,19)20)9-25-16(27-15)26-10-5-14(13(6-21)24-7-10)28-11-3-2-4-23-8-11/h5,7,9,11,23H,2-4,8H2,1H3,(H2,22,25,26,27)/t11-/m1/s1
Standard InChI Key: BTPZYXQYPWFYBC-LLVKDONJSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
12.5138 -4.7422 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.9306 -4.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1089 -4.0278 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.6391 -4.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6379 -5.2687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3501 -5.6776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0639 -5.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0611 -4.4414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3483 -4.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7764 -5.6757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4876 -5.2660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1967 -5.6739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9074 -5.2649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9066 -4.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1891 -4.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4813 -4.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9311 -3.2111 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.3459 -3.2107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0565 -2.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6141 -4.0301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3206 -3.6194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1850 -3.2099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8947 -2.7977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6073 -3.2082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3108 -2.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3108 -1.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6012 -1.5665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8874 -1.9810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
4 2 1 0
2 17 1 0
9 18 1 0
18 19 1 0
20 21 3 0
14 20 1 0
15 22 1 0
23 22 1 1
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.37Molecular Weight (Monoisotopic): 393.1525AlogP: 2.68#Rotatable Bonds: 5Polar Surface Area: 107.78Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.65CX Basic pKa: 9.37CX LogP: 1.56CX LogD: 0.13Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.71Np Likeness Score: -1.16
References 1. Jin T, Xu L, Wang P, Hu X, Zhang R, Wu Z, Du W, Kan W, Li K, Wang C, Zhou Y, Li J, Liu T.. (2021) Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile., 64 (20.0): [PMID:34665631 ] [10.1021/acs.jmedchem.1c00994 ]